ZIOPHARM Oncology (ZIOP) Posts Q3 Loss of $0.13, Better Y/Y
More News related to ZIOP
- ZIOPHARM Oncology (ZIOP) Posts Q3 Loss of $0.13, Better Y/Y
- ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
- ZIOPHARM to Host Analyst & Institutional Investor Meeting on November 19, 2009
- Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
- ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reports Q3 loss of $0.13, compared to ($0.26) in the same quarter last year.
Related Categories
EarningsStocks Mentioned
+0.16Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
